CLINICAL TRIALS AND OBSERVATIONS Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
نویسندگان
چکیده
Francesca Gay,1 Alessandra Larocca,1 Pierre Wijermans,2 Federica Cavallo,1 Davide Rossi,3 Ron Schaafsma,4 Mariella Genuardi,1 Alessandra Romano,5 Anna Marina Liberati,6 Agostina Siniscalchi,7 Maria T. Petrucci,8 Chiara Nozzoli,9 Francesca Patriarca,10 Massimo Offidani,11 Roberto Ria,12 Paola Omedè,1 Benedetto Bruno,1 Roberto Passera,13 Pellegrino Musto,14 Mario Boccadoro,1 Pieter Sonneveld,15 and Antonio Palumbo1
منابع مشابه
CLINICAL TRIALS AND OBSERVATIONS Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience
The POEMS syndrome (polyradiculoneuropathy, organomegaly, multiple endocrinopathies, monoclonal protein, skin changes) is a rare disease associated with a plasma cell dyscrasia. Patients with disseminated POEMS can be treated with high-dose therapy and autologous stem cell transplantation (ASCT). While clinical improvement is nearly universal in these patients, the long-term outcomes after tran...
متن کاملCLINICAL TRIALS AND OBSERVATIONS High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up
Severe aplastic anemia (SAA) is a lifethreatening bone marrow failure disorder that can be treated with bone marrow transplantation, immunosuppressive therapy,and high-dose cyclophosphamide. Here, we report long-term follow-up on 67 SAA patients (44 treatment-naiveand23refractory) treated with high-dose cyclophosphamide. At 10 years, the overall actuarial survival was 88%, the response rate was...
متن کاملAlternate endpoints for screening phase II studies.
Phase II trials are screening trials that seek to identify agents with sufficient activity to continue development and those for which further evaluation should be halted. Although definitive phase III trials use progression-free or overall survival to confirm clinical benefit, earlier endpoints are preferable for phase II trials. Traditionally, tumor shrinkage of a predetermined degree (respon...
متن کاملCLINICAL TRIALS AND OBSERVATIONS Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Optimal management of patients with relapsed/refractory chronic lymphocytic leukemia (CLL) is dictated by patient characteristics, prior therapy, and response to prior therapy. We report the final analysis of combined fludarabine, cyclophosphamide, and rituximab (FCR) for previously treated patients with CLL and identify patients who benefit most from this therapy. We explore efficacy of FCR in...
متن کاملCLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin
The nucleoside analogue, pentostatin, has demonstrated high complete response rates and long relapse-free survival times in patients with hairy cell leukemia, a disease that historically had been unresponsive to treatment. Long-term data on duration of overall survival and relapsefree survival and incidence of subsequent malignancies with this agent are lacking. Patients completing the treatmen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2011